Advances in the diagnosis of heparin-induced thrombocytopenia

In this episode, Anand Padmanabhan, M.B.B.S., Ph.D., a physician-scientist and consultant in the divisions of Hematopathology, Transfusion Medicine, and Experimental Pathology at Mayo Clinic, discusses new ways to detect heparin-induced thrombocytopenia antibodies.

Show Notes

Timestamps:

00:00 Intro

01:00 What is HIT and why is it important for clinicians to correctly diagnose HIT? 

03:30 What do we know about how laboratory testing may help clinicians get the diagnosis right?

 

07:25 How could the process of diagnosing HIT be updated or made better?

10:45 What does the future hold for HIT testing? In five years’ time what do you think HIT testing is going to look like in this country?

12:45 How has your relationship with your clinical colleagues helped advance your practice of medicine? 

15:30 Outro

Related Resources:

Conference: A Case-Based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis

Article: National Symposium Focuses on Bleeding and Thrombotic Disorders

What is Lab Medicine Rounds?

A Mayo Clinic podcast for laboratory professionals, physicians, and students, hosted by Justin Kreuter, M.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, featuring educational topics and insightful takeaways to apply in your practice.